Trevi completes enrollment in itching drug trial
Trevi Therapeutics, which is developing a drug to treat chronic itching in patients with the skin condition prurigo nodularis, has completed enrollment in its latest...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Trevi Therapeutics, which is developing a drug to treat chronic itching in patients with the skin condition prurigo nodularis, has completed enrollment in its latest...
View this email in your browser Weekly Roundup – February 10, 2022 This week was National Black HIV/AIDS Awareness Day. Despite significant progress, there continues to...
Guilford’s Butterfly Network plans to partner with software firm Ambra Health to expand the capabilities of its bedside ultrasound device. Butterfly Network will integrate Ambra’s software into its...
Eastern Connecticut State University honored one of its most notable champions when it named the Science Building on campus after David G. Carter Sr., the University’s...
Black History Month: Black trailblazers in science and biotechnology that you need to know about. more
Sema4 and Miami-based OPKO Health Inc., a multinational biopharmaceutical and diagnostics company, signed a definitive agreement for Sema4 to acquire OPKO’s wholly owned subsidiary, GeneDx...
osh Geballe will join Yale as its senior associate provost for entrepreneurship & innovation. In the new role, Geballe, an experienced technology professional and current member of...
Stem cells have been used for years as therapeutics for human health, but new research shows they may offer the promise of making the global...
View this email in your browser Weekly Roundup – February 3, 2022 Artizan Biosciences was recently named January’s ‘Innovator of the Month‘ by Senator Chris Murphy....
Two startup bioscience companies backed by well-known local entrepreneurs have signed leases for space in the new Elm City Bioscience Center. The tenants are Aztek Bio, founded...